Prelude Capital Management, LLC Assembly Biosciences, Inc. Transaction History

Prelude Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $1,948 - $6,916	-400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.08 - $27.04 $6,032 - $10,816	400 New	400 $7,000
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $8,817 - $13,293	-897 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $11,571 - $18,657	897 New	897 $12,000
Q3 2018 Nov 14, 2018	SELL	$34.41 - $44.23 $34,410 - $44,230	-1,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $54,894 - $70,406	-1,400 Reduced 58.33%	1,000 $39,000
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $100,080 - $153,984	2,400 New	2,400 $118,000
Q4 2017 Feb 14, 2018	SELL	$28.58 - $49.91 $28,580 - $49,910	-1,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $23,080 - $34,920	1,000	1,000 $35,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.